Dalton, Greiner, Hartman, Maher & Co’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-14,258
Closed -$1.57M 40
2021
Q1
$1.57M Sell
14,258
-6,552
-31% -$711K 1.24% 11
2020
Q4
$2.09M Sell
20,810
-1,431
-6% -$133K 0.44% 69
2020
Q3
$1.74M Sell
22,241
-13,091
-37% -$987K 0.28% 117
2020
Q2
$2.46M Sell
35,332
-32,428
-48% -$2.04M 0.24% 136
2020
Q1
$3.16M Sell
67,760
-11,507
-15% -$739K 0.33% 118
2019
Q4
$6.28M Sell
79,267
-2,143
-3% -$165K 0.43% 96
2019
Q3
$6.01M Buy
81,410
+69,838
+604% +$5.01M 0.41% 95
2019
Q2
$901K Sell
11,572
-217
-2% -$16.5K 0.07% 156
2019
Q1
$895K Sell
11,789
-17,947
-60% -$1.43M 0.07% 156
2018
Q4
$2.17M Sell
29,736
-161,725
-84% -$12.9M 0.16% 121
2018
Q3
$18.3M Buy
191,461
+5,045
+3% +$500K 0.92% 51
2018
Q2
$18.6M Buy
186,416
+85,021
+84% +$8.98M 0.96% 41
2018
Q1
$10.7M Sell
101,395
-112,925
-53% -$11.4M 0.72% 59
2017
Q4
$19.9M Sell
214,320
-23,819
-10% -$2.16M 1.04% 35
2017
Q3
$21.5M Sell
238,139
-2,463
-1% -$210K 1.21% 19
2017
Q2
$20.2M Sell
240,602
-1,317
-0.5% -$106K 1.17% 22
2017
Q1
$19.5M Sell
241,919
-4,610
-2% -$363K 1.11% 31
2016
Q4
$18.5M Sell
246,529
-1,917
-0.8% -$138K 1.08% 33
2016
Q3
$16.8M Buy
248,446
+70,084
+39% +$4.7M 1.09% 24
2016
Q2
$12.1M Sell
178,362
-12,958
-7% -$952K 0.75% 74
2016
Q1
$13.8M Sell
191,320
-50,810
-21% -$3.33M 0.85% 59
2015
Q4
$16.3M Sell
242,130
-26,732
-10% -$1.87M 0.94% 45
2015
Q3
$17.4M Sell
268,862
-15,797
-6% -$1.17M 0.98% 36
2015
Q2
$23.3M Sell
284,659
-16,831
-6% -$1.3M 1.21% 24
2015
Q1
$20.9M Sell
301,490
-10,800
-3% -$780K 1.17% 31
2014
Q4
$23.7M Buy
312,290
+29,533
+10% +$2.33M 1.31% 28
2014
Q3
$22.9M Buy
+282,757
New +$23.6M 1.3% 30

Other funds holding EMN

Dalton, Greiner, Hartman, Maher & Co's EMN Position: Q2 2021 in Review

Dalton, Greiner, Hartman, Maher & Co sold out of Eastman Chemical (EMN) in Q2 2021, closing a stake of 14,258 shares — an estimated $1.57M sold.

Dalton, Greiner, Hartman, Maher & Co first reported a position in EMN in Q3 2014 and held it in 27 quarters. The position peaked at $23.7M in Q4 2014. 724 funds tracked by Wall St. Rank hold EMN as of Q2 2021.

  • Dalton, Greiner, Hartman, Maher & Co reported no remaining Eastman Chemical position as of Q2 2021 after selling out during the quarter.
  • Dalton, Greiner, Hartman, Maher & Co sold 14,258 Eastman Chemical shares in Q2 2021, an estimated $1.57M.
  • Dalton, Greiner, Hartman, Maher & Co first reported a position in Eastman Chemical in Q3 2014 and held it in 27 quarters.
  • Dalton, Greiner, Hartman, Maher & Co's Eastman Chemical position peaked at $23.7M in Q4 2014.
  • 724 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2021.

Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q2 2021.